Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

6
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
6
Crossover Experiments01:16

Crossover Experiments

3.9K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
3.9K
Clinical Trials01:16

Clinical Trials

9.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.5K
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

190
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
190
Hazard Ratio01:12

Hazard Ratio

283
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
283

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Defining rapid early progression in glioblastoma-A volumetric approach.

Neuro-oncology advances·2026
Same author

STEM in an SEM: Towards high-throughput imaging and analysis of metal nanoclusters.

Ultramicroscopy·2026
Same author

Cost-effectiveness of vorasidenib in treatment of isocitrate dehydrogenase-mutated low-grade glioma.

Cancer·2026
Same author

In Regard to Yu et al.

Practical radiation oncology·2026
Same author

Risks associated with ventriculomegaly and symptomatic communicating hydrocephalus following stereotactic radiosurgery for vestibular schwannoma.

Journal of neurosurgery·2026
Same author

Treatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation: A Randomized Clinical Trial.

JAMA·2026
Same journal

Identifying predictive factors for radiation necrosis vs local recurrence in biopsy-proven enlarging lesions post-stereotactic radiosurgery for brain metastases.

Neuro-oncology practice·2026
Same journal

Visual morbidity, long-term outcome and prognostic factors in infants and young children with optic pathway low-grade glioma.

Neuro-oncology practice·2026
Same journal

Transforming molecular neuropathology-Progress and persistent challenges in UK brain tumor care.

Neuro-oncology practice·2026
Same journal

Advancing the characterization of enlarging lesions after stereotactic radiosurgery: The combined role of clinical timing and dosimetric profiles in distinguishing radiation necrosis from tumor recurrence.

Neuro-oncology practice·2026
Same journal

AI-based framework to fuse pre-RT brain metastases contours with follow-up MRI to improve post-RT assessment.

Neuro-oncology practice·2026
Same journal

Negative impact of hippocampal radiotherapy dose on memory function in patients with brain metastases.

Neuro-oncology practice·2026
See all related articles

Related Experiment Video

Updated: Oct 5, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.7K

Missing repeated measures data in clinical trials.

Stephanie L Pugh1, Paul D Brown2, Danielle Enserro3

  • 1Department of Statistics, American College of Radiology, NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania, USA.

Neuro-Oncology Practice
|January 31, 2022
PubMed
Summary
This summary is machine-generated.

Missing data in clinical trials is common. Understanding its patterns and using appropriate statistical methods, like sensitivity analyses, ensures reliable study results.

Keywords:
longitudinal analysismissing datapatient-reported outcomes

More Related Videos

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.8K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

776

Related Experiment Videos

Last Updated: Oct 5, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.7K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.8K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

776

Area of Science:

  • Biostatistics
  • Clinical Trial Methodology
  • Data Science

Background:

  • Clinical trials generate longitudinal data from repeated measurements over time.
  • Missing data is a frequent issue in clinical trials due to patient dropout or missed assessments.
  • Identifying reasons and predictors of missing data is crucial for determining the underlying data mechanism.

Purpose of the Study:

  • To elucidate the impact of missing data mechanisms on clinical trial analysis.
  • To outline appropriate statistical methods based on different missing data assumptions.
  • To emphasize the importance of sensitivity analyses for robust interpretation of trial results.

Main Methods:

  • Exploration of statistical methods for ignorable and non-ignorable missing data.
  • Discussion of techniques such as mixed-effects models, multiple imputation, pattern-mixture models, and shared parameter models.
  • Highlighting the role of sensitivity analyses in assessing the impact of missing data assumptions.

Main Results:

  • The choice of analysis method is critically dependent on the missing data mechanism.
  • Non-ignorable missing data requires more complex modeling techniques with stronger assumptions.
  • Truly ignorable missing data is rare in clinical trials, necessitating advanced analytical approaches.

Conclusions:

  • Understanding missing data mechanisms is vital for accurate clinical trial interpretation.
  • Appropriate statistical methods must be selected based on the nature of missing data.
  • Sensitivity analyses are essential to evaluate the robustness of trial findings to missing data assumptions.